6WML
Human TLR8 bound to the potent agonist, GS-9688 (Selgantolimod)
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.1 |
| Synchrotron site | ALS |
| Beamline | 5.0.1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2016-11-10 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 0.9762 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 86.816, 141.575, 171.263 |
| Unit cell angles | 90.00, 90.41, 90.00 |
Refinement procedure
| Resolution | 47.860 - 2.500 |
| R-factor | 0.2115 |
| Rwork | 0.211 |
| R-free | 0.25500 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3w3k |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.542 |
| Data reduction software | XDS |
| Data scaling software | XDS |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 47.860 | 2.650 |
| High resolution limit [Å] | 2.000 | 2.500 |
| Rmeas | 0.060 | 0.498 |
| Number of reflections | 270193 | 22744 |
| <I/σ(I)> | 17.44 | |
| Completeness [%] | 98.1 | 98.9 |
| Redundancy | 3.2 | |
| CC(1/2) | 0.990 | 0.840 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 5 | 293 | 4% (w/v) PEG 3350 0.2 M potassium formate 0.1 M sodium citrate, pH 5.0 |






